Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical diclofenac sodium 3% for actinic keratoses
2007-003934-40Phase 3Completed
- Sponsor
- Help Pharmaceuticals
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in actinic keratosis (AK) comparing Diclofenac sodium 3% (Fenaraze) with Placebo (2 arms). Primary endpoint: Change in Target Lesion Number Score (TLNS). Started Dec 2007; status: completed.
02
Drugs
diclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2007-003934-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003934-40.